Last edited by Kagagul
Saturday, May 16, 2020 | History

5 edition of Eicosanoids in the cardiovascular and renal systems found in the catalog.

Eicosanoids in the cardiovascular and renal systems

  • 305 Want to read
  • 11 Currently reading

Published by MTP Press in Lancaster, Boston .
Written in English

    Subjects:
  • Heart -- Pathophysiology,
  • Kidneys -- Pathophysiology,
  • Arachidonic acid -- Derivatives -- Physiological effect,
  • Arachidonic Acids -- metabolism,
  • Cardiovascular System -- metabolism,
  • Eicosanoic Acids -- metabolism

  • Edition Notes

    Includes bibliographies and index.

    Statementedited by P.V. Halushka and D.E. Mais.
    SeriesAdvances in eicosanoid research
    ContributionsHalushka, Perry V., Mais, Dale E. 1952-
    Classifications
    LC ClassificationsRC669.9 .E38 1988
    The Physical Object
    Paginationx, 258 p. :
    Number of Pages258
    ID Numbers
    Open LibraryOL2405674M
    ISBN 100852009593
    LC Control Number87036644

    Renal Microvascular Interactions Between Hormonal and Paracrine Factors and Eicosanoids. Eicosanoid metabolites contribute importantly to the renal vascular responses to hormonal and other paracrine factors. Renal vasoconstriction to Ang II, ATP, AVP, and ET-1 is influenced by locally generated arachidonic acid metabolites [3, , ]. Together, the heart, blood and blood vessels make up a system called “the cardiovascular system.” Think of it as a delivery system. The delivery system moves blood from the heart carrying oxygen and nutrients throughout your body and also picks up waste products so that your body can get rid of them.

    Receptor Activity and Availability in the Cardiovascular System 45 Localization of SHRs in the Heart and Vessels of Rodent and Men 45 Receptor-Independent Effects of Sex Steroids 47 Sex Hormone Effects on Cardiovascular Cells and Organs 47 Sex Hormone Effects on Different Cardiovascular Cell Types Start studying Chapter 8: Drugs Affecting the Renal/Urinary and Cardiovascular Systems Book Notes. Learn vocabulary, terms, and more with flashcards, games, and other study tools.

    Michael Brands, PhD - Regents' Professor - Physiology. / [email protected] / CV Cardiovascular-renal integrative physiology and hypertension. Longstanding interest in renal and hormonal mechanisms for chronic blood pressure and circulatory system control in states of insulin resistance, hyperinsulinemia, and diabetes. Fatty acid sources "Eicosanoid" (eicosa-, Greek for "twenty"; see icosahedron) is the collective term for straight-chain polyunsaturated fatty acids (PUFAs) of 20 carbon units in length that have been metabolized or otherwise converted to oxygen-containing PUFA precursors to the eicosanoids include: Arachidonic acid (AA), i.e. 5Z, 8Z,11Z,14Z-eicosatetraenoic acid is ω-6 fatty.


Share this book
You might also like
Supranationalism in the new world order

Supranationalism in the new world order

Fish fry

Fish fry

Map publication and office work

Map publication and office work

Modern school hygiene

Modern school hygiene

Geological excursions in the Sheffield region and the Peak District national park

Geological excursions in the Sheffield region and the Peak District national park

Report on 2009-2010 masters program, Water-related Disaster Management Course of Disaster Management Policy Program

Report on 2009-2010 masters program, Water-related Disaster Management Course of Disaster Management Policy Program

Grist for the Mills

Grist for the Mills

Estrogen replacement therapy

Estrogen replacement therapy

Little Wild Horse Mesa quadrangle, Utah--Emery Co

Little Wild Horse Mesa quadrangle, Utah--Emery Co

Sketchbook.

Sketchbook.

Thats Dangerous

Thats Dangerous

Eicosanoids in the cardiovascular and renal systems Download PDF EPUB FB2

Eicosanoids in the Cardiovascular and Renal Systems (Advances in Eicosanoid Research) [Halushka, P. V.] on *FREE* shipping on qualifying offers. Eicosanoids in the Cardiovascular and Renal Systems (Advances in Eicosanoid Research)Format: Paperback.

The original series, Advances in Prostaglandin Research, edited by Sultan M. Karim, was published by MTP Press in three volumes in and A glance at those books illustrates the progress that has been made since then.

The thromboxanes were mentioned twice (first publication ) and. Although each book stands alone, the eicosanoids cut across many boundaries in their basic actions; selected chapters from each book in the series will provide illuminating and productive information for all readers which will advance their education and research.

Eicosanoids in the Cardiovascular and Renal Systems. Advances in Eicosanoid Research (Book 4) Share your thoughts Complete your review. Tell readers what you thought by rating and reviewing this book. Rate it * You Rated it *Brand: Springer Netherlands.

Eicosanoids in the cardiovascular and renal systems. Lancaster ; Boston: MTP Press, © (OCoLC) Online version: Eicosanoids in the cardiovascular and renal systems.

Lancaster ; Boston: MTP Press, © (OCoLC) Document Type: Book: All Authors / Contributors: Perry V Halushka; Dale E Mais. Eicosanoids in the Cardiovascular and Renal Systems. [P V Halushka; D E Mais] -- The original series, Advances in Prostaglandin Research, edited by Sultan M.M.

Karim, was published by MTP Press in three volumes in and It includes new topics such as prostaglandin synthetase enzyme, new synthetic eicosanoids, innovative analytical methods, the influence of cytokines in the regulation of synthesis and actions, newer eicosanoids that influence the cardiovascular system, and newly discovered roles in reproduction and interactions with nitric oxide.

Eicosanoids in the Cardiovascular and Renal Systems. por. Advances in Eicosanoid Research (Book 4) ¡Gracias por compartir. Has enviado la siguiente calificación y reseña. Lo publicaremos en nuestro sitio después de haberla : Springer Netherlands. Abstract. Platelets and smooth muscle cells have been implicated in the development of coronary atherosclerosis and its complications.

The potent effects of thromboxane A 2 and other cyclo-oxygenase products of arachidonic acid on these cell types, their production by tissues contiguous with diseased vessels and their local site of action suggest that these eicosanoids may be important in the.

Eicosanoids are biologically active molecules made by oxidation of either ω‐3 or ω‐6 20‐carbon fatty acids. Eicosanoids are grouped into subcategories including leukotrienes, lipoxins, hydroxy‐eicosatetraenoic acids, hydroxy‐eicosapentaenoic acids, eoxins, isoprostanes, resolvins and prostanoids (Figure 1).

Renal vascular generation of eicosanoids is altered in pathophysiological conditions such as hypertension, diabetes, metabolic syndrome and acute renal failure.

The Renal System at a Glance: Offers clear explanations on tricky topics such as electrolytes, fluid balance and acid-base handling Features new sections on glomerular filtration, and a new chapter on the global differences in kidney problems Includes cross-referencing between basic science and related clinical content Focuses on clinical.

Prostaglandins, leukotrienes, and related eicosanoids have a modulatory function in mammalian cells and are responsible for tissue responses such as inflammation or wound repair. Increasing activity in eicosanoid research sheds new light on today's most common diseases including atherosclerosis, cancer, Alzheimer's, allergies, and rheumatic.

Schror, K.: Prostaglandins and Other Eicosanoids in the Cardiovascular System (Editorial) 1 Vane, J. R.: Prostacyclin in the Cardiovascular System in Health and Disease (Plenary Lecture) 7 Measurement of Eicosanoids Peskar, B.

(Moderator): Methods of Measurement of Eicosanoids. Eicosanoids are altered in cardiometabolic syndrome and contribute the progression of renal injury. The anti-hypertensive and anti-inflammatory actions of epoxides and soluble epoxide hydrolase inhibitors make these attractive eicosanoid therapeutic targets for chronic kidney disease in patients with cardiometabolic by: Martin Giera, Jean M.

Galano, in Encyclopedia of Analytical Science (Third Edition), Introduction. The eicosanoids owe their name to the fact that they are 20 carbon units in length (eicosa- “greek—twenty”). The eicosanoids derive from the Ω6-poly-unsaturated fatty acid (PUFA), arachidonic acid ((5 Z,8Z,11Z,14Z)-5,8,11,eicosatetraenoic acid) and related PUFA.

Abstract. Eicosanoids represent a diverse family of lipid mediators with fundamental roles in physiology and disease. Within the eicosanoid superfamily are prostanoids, which are specifically derived from arachidonic acid by the enzyme cyclooxygenase (COX).

COX has two isoforms; COX‐1 and COX‐ by: In the cardiovascular system, motion and flow can be imaged so that even flow velocities in the deep vessels of the body can be measured, and turbulences can be identified.

In the study of the kidneys, a combination of renally excreted contrast media and imaging provides within seconds insight into glomerular filtration in health and : Paperback. Inhibitors of Eicosanoids. The Eicosanoids In book: The Eicosanoids, pp - an alarming turn of events took place in the late period when rofecoxib was withdrawn worldwide.

Moreover, cyclooxygenase- and lipoxygenase-derived products have been implicated in various types of cardiac dysfunction including coronary constriction, arrhythmogenesis, anaphylactic reactions, or ischemic and reperfusion view of the evolving complexity of arachidonic acid metabolism and increasing evidence that eicosanoids, either.

The original series, Advances in Prostaglandin Research, edited by Sultan M. M. Karim, was published by MTP Press in three volumes in and A glance at those books illustrates the progress that has been made since then.MRI has opened up new possibilities in combined morphological and functional imaging, and now there is a book which discusses both aspects together.

Two systems which already demonstrate the advantages of MRI are presented. In the cardiovascular system, motion and flow can be imaged so that even.Arachidonic acid metabolites are vital for the proper control of renal haemodynamics and, when not properly controlled, can contribute to renal vascular injury and end-stage renal disease.

Three major enzymatic pathways, COX (cyclo-oxygenase), CYP (cytochrome P) and LOX (lipoxygenase), are responsible for the metabolism of arachidonic acid metabolites to bioactive eicosanoids.

These Cited by: